Molecule to Market: Inside the outsourcing space – Détails, épisodes et analyse

Détails du podcast

Informations techniques et générales issues du flux RSS du podcast.

Molecule to Market: Inside the outsourcing space

Raman Sehgal

Sciences

Fréquence : 1 épisode/8j. Total Éps: 280

Molecule to Market takes you inside the global pharma and biopharma outsourcing ecosystem. Each week, our host Raman Sehgal sits down with the founders, entrepreneurs, CEOs and C-suite leaders shaping the pharma services and tools that power discovery, drug development and commercialization.

Listeners get real stories and practical insights from across the entire value chain, from big pharma and emerging biotechs to private equity investors, CROs, CDMOs, technology platforms and specialist consulting firms. Our host Raman is an entrepreneur, investor, bestselling author, speaker and long time industry insider.

https://moleculetomarketpod.com

Lire plusRéduire

Site

RSS

Apple

Classements récents

Dernières positions dans les classements Apple Podcasts et Spotify.

Apple Podcasts

🇫🇷 France - lifeSciences
17/08/2026
#94
🇫🇷 France - lifeSciences
16/08/2026
#82
🇫🇷 France - lifeSciences
15/08/2026
#72
🇫🇷 France - lifeSciences
14/08/2026
#59
🇫🇷 France - lifeSciences
13/08/2026
#48
🇫🇷 France - lifeSciences
12/08/2026
#29
🇫🇷 France - lifeSciences
11/08/2026
#40
🇫🇷 France - lifeSciences
10/08/2026
#34
🇫🇷 France - lifeSciences
09/08/2026
#22
🇫🇷 France - lifeSciences
08/08/2026
#17

Spotify

Aucun classement récent disponible

Liens partagés entre épisodes et podcasts

Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.

https://www.ramarketingpr.com/
187 partages
https://www.moleculetomarketpod.com/
39 partages
https://leadcandidate.com/
38 partages

https://www.linkedin.com/in/ramansehgalus/
34 partages
https://www.linkedin.com/in/langedirk/
7 partages
https://www.linkedin.com/in/elisabethstampa/
6 partages

https://podcasts.apple.com/us/podcast/molecule-to-market-inside-the-outsourcing-space/id1509290866
54 partages

Qualité et score du flux RSS

Évaluation technique de la qualité et de la structure du flux RSS.

Qualité du flux RSS

À améliorer

Score global : 52%

Historique des publications

Répartition mensuelle des publications d'épisodes au fil des années.

Year

Derniers épisodes publiés

Liste des épisodes récents, avec titres, durées et descriptions.

One-hour special - The President of the PBOA

Épisode 184

vendredi 30 août 2024 • Durée 01:02:29

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA).

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Gil, covering:

The evolution of the PBOA over the last decade, the impact of M&A on the Association, and building a safe place where CDMOs belong
How the industry has evolved over the last few years after Covid, including harder times and areas of green shoots
Why Gil believes Novo's purchase of Catalent is a black swan event and not a new megatrend
A deeper dive into fine details of The BIOSECURE Act, and its potential impact on the CDMO space over the next 7-8 years
The need to know market headwinds and tailwinds that you simply cannot ignore

Gil Roth is the Founder and President of the Pharma & Biopharma Outsourcing Association (PBOA), a nonprofit trade group that advocates for the regulatory, legislative and general business interests of the CMO/CDMO sector. In this role, he brings CDMO perspectives and education to FDA, the US Congress, and other bodies, and brings CDMOs together to share best practices, develop policy positions, and provide briefings on government positions that impact that sector. He also organizes and hosts PBOA's annual members-only Meeting & Conference.

Previously, he was the Founding Editor of Contract Pharma magazine. In his alleged free time, he produces a weekly cultural conversation podcast called the Virtual Memories Show (https://chimeraobscura.com/vm)

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

Lire plusRéduire

The puzzle-solving CEO

Épisode 183

vendredi 23 août 2024 • Durée 56:02

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Steven Chevillotte, Chief Executive Officer at SaniSure.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Steven, covering:

Building a great partner through professionalization and integration while retaining founder DNA of entrepreneurship and innovation
The transformation of quality components and complex assemblies to game changing systems and solutions
How SaniSure differentiates from smaller and larger bioprocessing organizations
Why exceptionally robust and clean products coupled with excellence in customized components and designing flow paths make SaniSure the partner of choice for Advanced Therapies (Eg: Cell Therapy)
Making the bioprocessing supply chain more robust

SaniSure CEO Steven has held senior leadership roles in finance, operations, and general management at precision manufacturing businesses, always in highly engineered and highly regulated industries, including Class III Medical Devices and Aerospace & Defense. Has learned best practices at large public and private companies and has developed an expertise and passion for hands-on transformation through strategy deployment. He is experienced with M&A and integration in PE-backed environments and has led a successful exit process. Steve holds Masters degrees in Manufacturing Systems Engineering and Financial Analysis & Accountancy.

Molecule to Market is sponsored and funded by , an international marketing, design, digital and content agency helping comp

The boomerang boy impacting gene therapies

Épisode 174

vendredi 7 juin 2024 • Durée 56:22

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Andy Holt, CCO of Viralgen Vector Core.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Andy, covering:

Growing a CDMO while dealmaking in a gene therapy company…at the same time
Selling a revenue-generating therapy company to Bayer during the pandemic
Faster failure or faster acceleration; the need to celebrate every gene therapy batch as it’s going to save lives
The challenges of manufacturing AAV gene therapies and why the next generation of CGT CDMOs need a voice at the table

Andy has been working on the business side of cell and gene therapy for more than 15 years, focused on creatively connecting science and solutions, whether health care for whale sharks or supporting multi-billion dollar transactions between biotech and big pharma.

Along the way, he has held positions in business development and management for several large CDMOs like Lonza and MilliporeSigma, leadership positions in Askbio, Ncardia, and Cellistic, and his current role as Chief Commercial Officer for Viralgen, a pioneering AAV-focused CDMO leveraging Askbio’s manufacturing expertise for clients around the world.

Africa’s biotech butterfly

Épisode 84

lundi 27 juin 2022 • Durée 43:11

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adrienne Leussa, Director of Ecosystem Partnerships at 54gene.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adrienne, covering:

How the reality of the health challenges living in Africa as a child drove Adrienne into the drug discovery space.
A rich insight into the only remaining high growth market globally for pharma companies.
Learn about the main cities driving drug development growth within Africa and the prospect for more localised manufacturing.
Life working for one of the leading biotech companies in Africa.
Living life by curiosity as an ethos to make a lasting impact in the world.

Adrienne is a Biochemist (PhD) with 10+ years of hands-on experience and a plethora of diverse technical skills within the area of drug discovery and development. She has also worked as a lecturer and researcher in top African universities helping inspire a generation of scientists through access to information on the applications of biotechnology.She is fluent in 3 of the most used languages in Africa: Portuguese, French and English, and is ardent about continued learning, cross-culture collaboration, problem solving, customer service and mentoring.Adrienne’s mission is to elevate Africa through high quality, innovative, and credible scientific output for global prosperity.

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

The global pharma leader with an eye on societal impact

Épisode 83

lundi 20 juin 2022 • Durée 51:48

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with David Enloe, President and CEO at Societal™ CDMO. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with David, covering:

Being at the birth of viral vectors and the-infant gene therapy field in the 90s... but choosing not to be there today.
After a career spent all over the world - he shares his pearls of wisdom of what he’s learnt from a lifetime of international business.
Navigating business confusion and redefining companies from the inside out, while focusing on people and patients.
Being a humble, humane, empathetic leader that does not take himself too seriously... and makes decisions quickly.
Uncertainty around the capital markets and what this means to the CDMO space in terms of potential headwinds.

David has over two decades of executive leadership experience in biotechnology, clinical drug development, and GMP manufacturing.He was CEO at Ajinomoto Bio-Pharma Services, CEO at Althea CMO and also served as head of Lonza’s Viral Therapeutics Business Unit, which resulted from Lonza’s acquisition of Vivante GMP Solutions. Prior to that, he spent 14 years with a biotech company, Introgen Therapeutics, and played an integral part in taking the company through a successful IPO in 2020.

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Lire plusRéduire

From PhD to Pioneer

Épisode 82

vendredi 17 juin 2022 • Durée 41:55

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ata Tuna Ciftlik CEO at Lunaphore.Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ata, covering:

Bringing the next generation ‘satellite for tumours’ sequencing tools for immuno oncology and cancer research to drug discovery, and eventually the mainstream.
Why life science start-ups need data to survive and thrive. And key lessons of entrepreneurship, from theory to reality.
The avalanche effect - from a 2.5k competition fundraise to $50m in a market on-track to become $10b.
Unmissable leadership lessons from PhD-start up to global life science business.

Ata Tuna Ciftlik was born in Ankara, Turkey. He received a double-B.Sc in Mathematics and Electronics Engineering from Middle East Technical University (METU) in 2006. He started interdisciplinary research at the interface of Microfluidics and Biology during his MSc studies in METU, where he received thesis of the year 2009 prize.

Next, he obtained interdisciplinary PhD in Biomedical Microfluidic Systems from Swiss Institute of Technology in Lausanne (EPFL) and was awarded internationally known Dimitris N. Chorafas foundation prize in the category of cutting egde technology.After inventing its core technology during his PhD, he has co-founded Lunaphore in 2014.

Lunaphore so far received USD 60 million financing from private and public sources, lead multiple innovation projects in Switzerland and Europe, counts close to 100 people, appeared more than 100 times in national and international media channels, claimed 22 awards and has consistently been selected as one of the best start-ups in the country. Ata Tuna is married, has 2 children and enjoys biking, running and hiking.

Supply chain challenges and trends

Épisode 81

vendredi 10 juin 2022 • Durée 28:57

In this special one-off episode of Molecule to Market, your host Raman Sehgal embarks on a solo cast to cover some of the major supply chain themes uncovered through Molecule to Market interviews. The insights were originally delivered live on stage at CPhI North America 2022. Whether you’re a CDMO, CPO, drug sponsor or equipment vendor - this is not to be missed.Your host, Raman, covers:

4 main challenges the sector has felt over the last two years
4 solutions we are seeing and that you may want to think about
4 trends you need to know for your business

Along with being the host of Molecule to Market, Raman Sehgal is the founder of PE-backed ramarketing, co-founder of Lead Candidate, and best-selling author of The Floundering Founder.Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Lire plusRéduire

Chats from CPhI North America

Épisode 80

vendredi 27 mai 2022 • Durée 22:59

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who discusses the pharmaceutical and biotechnology supply chain live from CPhI North America 2022, with:

Robert Lee, President at Lubrizol Life Science Health - CDMO Division at The Lubrizol Corporation
Lauren (Naughton) Hanna, Publisher at Contract Pharma
Bob Macadangdang, Client Development Manager at Sharp, Contract Pharmaceutical Packaging
Stephen Houldsworth, VP, Global Head of Platform Management & Marketing - Corden Pharma International
Claire Robinson, Partnership Manager at Sterling Pharma Solutions

What are the biggest challenges in our space? What are the latest trends? What should you be aware of? Listen and find out what our guests think!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed.

Lire plusRéduire

The BioPharmGuy

Épisode 79

lundi 16 mai 2022 • Durée 43:16

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Adam Wilson, President - BioPharmGuy. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Adam, covering:

The humble start-up story and journey of the biopharmguy.
The pivot that took the website from being a job sharing site to one of the most widely-regarded and used platforms in the biotech world.
The value of simply focussing on looking after your product as your fundamental market differentiator.
Poking fun at the sector and being a source of entertainment as well as information.

Adam is the BioPharmGuy. Prior to running BioPharmGuy full-time, he worked as a Process Development Engineer at a public biotech, an FDA Investigator and a Lab Tech in a dermatology research lab at a nonprofit hospital. His various experiences have contributed to his knowledge of the biotech industry which has enabled BioPharmGuy to become the best biotech company directory in existence. He independently created and built BioPharmGuy.com which now receives 40,000+ unique visitors every month.

The website built around a database of information on biotech, pharmaceutical, medical device and life science companies around the world. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences, get noticed. Your host Raman Sehgal is the author of The Floundering Founder.

Chronicles of Swiss Biotech day

Épisode 78

mercredi 11 mai 2022 • Durée 26:26

Event season is truly well on its way and where better to start than Swiss Biotech Day, the leading biotechnology conference in Switzerland. Renowned for its innovative biotech start-ups and big pharma companies all in attendance, it was a great chance to meet experts from the life science industry from across Europe. Which is why it should come as no surprise that your host Raman Sehgal brought Molecule to market once more to the event space.

If you loved the ‘Memoir of DCAT 2022’ episode, this is a pod for you as he hit the event space again in style and interviewed some more great guests along the way. Listen to a diverse range of our guests’ thoughts during this event.

Richard Collins, Managing Director Bio2Business Ltd
Hanns-Christian Mahler, CEO at ten23 health
Stefano Console, Founder & Senior Advisor at Oriento SA
Philippe Tschopp, Head of Business Development CDMO Glatt

Molecule to Market is sponsored and funded by ramarketing. An international content, design and digital agency that helps companies in life sciences get noticed.

Podcasts Similaires Basées sur le Contenu

Découvrez des podcasts liées à Molecule to Market: Inside the outsourcing space. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !